Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies.

Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies.
复制标题

DOI:
10.1038/s41419-018-0990-2
复制
发表时间:
2018-09-17
影响因子:
9
通讯作者:
Vescovi AL
Vescovi AL
中科院分区:
生物学1区
文献类型:
--
作者:
Rosati J;Ferrari D;Altieri F;Tardivo S;Ricciolini C;Fusilli C;Zalfa C;Profico DC;Pinos F;Bernardini L;Torres B;Manni I;Piaggio G;Binda E;Copetti M;Lamorte G;Mazza T;Carella M;Gelati M;Valente EM;Simeone A;Vescovi AL

文献摘要

参考文献

被引文献

相似文献

Establishing specific cell lineages from human induced pluripotent stem cells (hiPSCs) is vital for cell therapy approaches in regenerative medicine, particularly for neurodegenerative disorders. While neural precursors have been induced from hiPSCs, the establishment of hiPSC-derived human neural stem cells (hiNSCs), with characteristics that match foetal hNSCs and abide by cGMP standards, thus allowing clinical applications, has not been described. We generated hiNSCs by a virus-free technique, whose properties recapitulate those of the clinical-grade hNSCs successfully used in an Amyotrophic Lateral Sclerosis (ALS) phase I clinical trial. Ex vivo, hiNSCs critically depend on exogenous mitogens for stable self-renewal and amplification and spontaneously differentiate into astrocytes, oligodendrocytes and neurons upon their removal. In the brain of immunodeficient mice, hiNSCs engraft and differentiate into neurons and glia, without tumour formation. These findings now warrant the establishment of clinical-grade, autologous and continuous hiNSC lines for clinical trials in neurological diseases such as Huntington’s, Parkinson’s and Alzheimer’s, among others.
DOI: 10.1006/dbio.2000.9962
发表时间: 2001-01-01
影响因子: 2.7
作者:
Hartfuss, E;Galli, R;Götz, M
通讯作者: Götz, M
DOI: 10.1158/0008-5472.can-04-1364
发表时间: 2004-10-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Galli, R;Binda, E;Vescovi, A
通讯作者: Vescovi, A
DOI: 10.1002/cne.901930316
发表时间: 1980-01-01
影响因子: 2.5
作者:
LEVITT, P;RAKIC, P
通讯作者: RAKIC, P
DOI: 10.1007/s12015-016-9662-8
发表时间: 2016-08-01
影响因子: 4.8
作者:
Baghbaderani, Behnam Ahmadian;Syama, Adhikarla;Rao, Mahendra S.
通讯作者: Rao, Mahendra S.
DOI: 10.1016/j.omtm.2016.11.005
发表时间: 2017-03-17
期刊: Molecular therapy. Methods & clinical development
影响因子: --
作者:
Irion S;Zabierowski SE;Tomishima MJ
通讯作者: Tomishima MJ